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Characterization of Human and Mouse Peroxiredoxin IV:
Evidence for Inhibition by Prx-IV of Epidermal Growth
Factor- and p53-Induced Reactive Oxygen Species
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HSIANG-FU KUNG,1 KUAN-TEH JEANG,3 and DONG-YAN JIN1,3
ABSTRACT
The aim of this study was to identify and characterize human and mouse Prx-IV. We identified mouse peroxire-
doxin IV (Prx-IV) by virtue of sequence homology to its human ortholog previously called AOE372. Mouse Prx-
IV conserves an amino-terminal presequence coding for signal peptide. The amino acid sequences of mature mouse
and human Prx-IV share 97.5% identity. Phylogenetic analysis demonstrates that Prx-IV is more closely related to
Prx-I/-II/-III than to Prx-V/-VI. Previously, we mapped the mouse Prx-IV gene to chromosome X by analyzing two
sets of multiloci genetic crosses. Here we performed further comparative analysis of mouse and human Prx-IV ge-
nomic loci. Consistent with the mouse results, human Prx-IV gene localized to chromosome Xp22.135–136, in close
proximity to SAT and DXS7178. A bacterial artificial chromosome (BAC) clone containing the complete human
Prx-IV locus was identified. The size of 7 exons and the sequences of the splice junctions were confirmed by PCR
analysis. We conclude that mouse Prx-IV is abundantly expressed in many tissues. However, we could not detect
Prx-IV in the conditioned media of NIH-3T3 and Jurkat cells. Mouse Prx-IV was specifically found in the nucleus-
excluded region of cultured mouse cells. Intracellularly, overexpression of mouse Prx-IV prevented the produc-
tion of reactive oxygen species induced by epidermal growth factor or p53. Taken together, mouse Prx-IV is likely
a cytoplasmic or organellar peroxiredoxin involved in intracellular redox signaling. Antiox. Redox Signal. 2, 507–518.
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INTRODUCTION
PEROXIREDOXINS ARE A NEW FAMILY of antioxi-dant enzymes abundantly found in living
organisms ranging from bacteria to human
(Chae et al., 1994b; Jin and Jeang, 2000). Repre-
sentative microbial and mammalian peroxire-
doxins have been characterized as a terminal
peroxidase, which reduces hydrogen peroxide
and/or organic hydroperoxides using thiore-
doxin, tryparedoxin, glutathione, or other mol-
ecules as electron donor (Chae et al., 1994a; Jin
et al., 1997; Kang et al., 1998a,b; Montemartini
et al., 1998; Singh and Shichi, 1998; Fisher et al.,
1999). All peroxiredoxin proteins conserve a
structural motif surrounding a cysteine
residue, which is the peroxidatic center (Chae
et al., 1994b; Choi et al., 1998; Hirotsu et al.,
1999). The ubiquity and high conservation of
peroxiredoxins suggest that they may have im-
portant roles in antioxidant defense and redox
signaling. Indeed, several lines of evidence
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support that peroxiredoxins can influence re-
ceptor signaling, protein phosphorylation,
gene expression, and apoptosis (Ichimiya et al.,
1997; Jin et al., 1997; Zhang et al., 1997; Kang et
al., 1998b; Kowaltowski et al., 1998; Araki et al.,
1999).
Multiple subtypes of peroxiredoxins are of-
ten found in one species. Thus, there exist three
peroxiredoxins (AhpC, Tpx/scavengase p20,
and BCP) in Escherichia coli (Chae et al., 1993,
1994b, Cha et al., 1995, 1996; Wan et al., 1997;
Zhou et al., 1997; Jin and Jeang, 2000), and five
(TSA1, TSA2, BCP, 1CPrx, and PMP20) in bud-
ding yeast (Chae et al., 1994a; Jeong et al., 1999;
Lee et al., 1999; Verdoucq et al., 1999). As yet,
six subfamilies (I–VI) have been identified in
mammals (Chae et al., 1994b; Frank et al., 1997;
Jin et al., 1997; Haridas et al., 1998; Kang et al.,
1998a,b; Lim et al., 1998; Singh and Shichi, 1998;
Knoops et al., 1999; Kropotov et al., 1999; Lyu
et al., 1999; Matsumoto et al., 1999; Yamashita
et al., 1999; Zhou et al., 2000). Mammalian per-
oxiredoxins are abundantly expressed in cells.
However, different subtypes show distinct tis-
sue distribution patterns and target to different
subcellular compartments (Jin et al., 1997; Kang
et al., 1998a,b; Montemartini et al., 1998; Singh
and Shichi, 1998; Araki et al., 1999; Matsumoto
et al., 1999; Sarafian et al., 1999). Thus, they may
serve tissue-specific functions at restricted sub-
cellular locations.
To understand the biological interplay be-
tween peroxiredoxins, it is imperative that one
identifies and characterizes all known perox-
iredoxins within each given species. Among
the six currently known subtypes of peroxire-
doxins in human, mouse, and rat, mouse Prx-
IV is the only one that has not been identified.
In addition, there is a discrepancy in the liter-
ature regarding the subcellular localization, se-
cretion, and biological functions of human and
rat Prx-IV (Jin et al., 1997; Haridas et al., 1998;
Matsumoto et al., 1999). Here, we have cloned
a full-length mouse Prx-IV cDNA through a
search for the mouse ortholog of the newly
identified human Prx-IV, previously known as
AOE372 (Jin et al., 1997). We performed phylo-
genetic analysis of mammalian peroxiredoxins
and comparative analysis of mouse and human
Prx-IV genomic loci. We also assessed the ex-
pression profiles, subcellular localization, and
secretion of mouse Prx-IV. Finally, we showed
that mouse Prx-IV is a functional intracellular
antioxidant enzyme.
MATERIALS AND METHODS
Materials
The expressed sequence tag (EST) cDNA
clone (I.M.A.G.E. Consortium clone 367356) en-
coding mouse Prx-IV was from the American
Type Culture Collections (Manassas, VA). The
mammalian expression plasmid for wild-type
human p53 (pp53; a gift from B. Vogelstein,
Johns Hopkins University Oncology Center,
Baltimore, Maryland) was described previously
(Kern et al., 1991). Plasmid pSVP4 was con-
structed by inserting the mouse Prx-IV cDNA
(coding for amino acids 1–274, including the 
putative signal peptide) into a previously de-
scribed (Jin et al., 1998) eukaryotic expression
vector with SV40 early promoter and enhancers.
The expression vector for b-galactosidase (pSV-
Gal) was purchased from Promega (Madison,
WI). Human genomic DNA from blood was
from Novagen (Madison, WI). EGF was from
Life Technologies (Rockville, MD).
Sequence analysis
Double-stranded mouse Prx-IV cDNA was
sequenced on both strands by the dideoxy ter-
mination method using Sequenase 2.0 (Amer-
sham, Piscataway, NJ). Multiple alignment of
Prx-IV protein sequences was generated with
programs in the Genetics Computer Group
software package (Version 10.0; GCG, Inc.,
Madison, Wisconsin). Presentation of the align-
ment was modified using the BOXSHADE pro-
gram (Version 3.21; http://www.ch.embnet.
org). Phylogenetic analysis was based on the
PHYLIP software package Version 3.573
(Felsenstein, 1996). Prediction of TATA box
was assisted by the TSSG/TSSW (available on
the Sanger Center server; http://genomic.
sanger.ac.uk) and the TFSEARCH (developed
by Yutaka Akiyama; http://www.rwcp.or.jp)
programs.
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Chromosomal mapping
The nucleotide sequence (GenBank AC005867)
of the bacterial artificial chromosome (BAC) clone
GSHB-567I1 previously mapped to human chro-
mosome Xp22.135–136 was used for physical
alignment of human Prx-IV. The flanking mark-
ers are SAT and DXS7178. The sequence and
mapping data were produced by the Baylor Col-
lege of Medicine Human Genome Sequencing
Center (http://www.hgsc.bcm.tmc.edu).
Northern and Western blot analysis
The mouse multiple tissue Northern blot
(CLONTECH, Palo Alto, California) was
probed with an , 1-kb 32P-labeled XhoI–HindIII
fragment of mouse Prx-IV using manufactuer’s
protocol.
Proteins from total extracts of cultured cells
were solubilized in sodium dodecyl sulfate
(SDS) gel loading buffer (60 mM Tris base, 2%
SDS, 10% glycerol, 5% 2-mercaptoethanol). Con-
centration of the culture medium was achieved
by ultrafiltration through a Centricon-10 con-
centrator (Amicon, Bedford, MA). Cell samples
containing 20 mg of protein and medium sam-
ples concentrated from 3 ml of culture medium
were separated by 12% SDS- polyacrylamide gel
electrophoresis (PAGE), and electroblotted onto
Immobilon-P membranes (Millipore, Bedford,
MA) using a Millipore semidry transfer appa-
ratus. Immunodetection was performed with a
rabbit antiserum (372-1) raised against a keyhole
limpet hemocyanin-conjugated synthetic Prx-IV
peptide, whose sequence is indicated in Fig. 2
(below). The blot was detected using chemilu-
minescence (Western-Light, Tropix, Bedford,
MA) using goat anti-rabbit antibody conjugated
to alkaline phosphatase. The primary and sec-
ondary antibodies were diluted to 1:1,000 and
1:10,000, respectively. NIH-3T3 cells were trans-
fected using the calcium phosphate method, and
transfection of Jurkat cells was achieved by elec-
troporation.
Confocal microscopy
Confocal laser-scanning immunofluores-
cence microscopy was performed as described
previously (Jin et al., 1997). The 372-1 rabbit
anti-Prx-IV antiserum described above was
used at 1:60 dilution. An argon ion laser with
an emission line at 488 nm was used to excite
fluorescein dye conjugated to a goat anti-rab-
bit IgG secondary antibody (1:50 dilution).
ROS detection
Intracellular reactive oxygen species (ROS)
were measured by confocal fluorescence mi-
croscopy using the dye 29, 79-dichlorodihydro-
fluorescein diacetate (Molecular Probes, Inc.,
Eugene, OR), which is oxidized by biological
oxidants to give the highly fluorescent 29,79-
dichlorofluorescein (DCF). Cultured A431 and
NIH-3T3 cells were harvested into medium
containing 0.2% fetal calf serum (FCS) and 10
mM fluorescent dye. After incubation for 8 min,
30 cells from each group were measured for flu-
orescent intensity under a confocal laser-scan-
ning microscope (Carl Zeiss, Esslingen, Ger-
many). DCF was excited by an argon ion laser
with an emission line at 488 nm. Cells were
transfected with the calcium phosphate
method. The p53-expressing cells were recog-
nized by staining with a mouse monoclonal
anti-p53 antibody (DO-1; Santa Cruz Biotech.,
Santa Cruz, CA). A helium-neon laser with an
emission line at 633 nm was used to excite Cya-
nine 5.18 conjugated to the secondary antibody
(goat anti-mouse IgG). Likewise, b-galactosi-
dase-expressing cells were selected by staining
with a mouse monoclonal anti-b-galactosidase
antibody (GAL-13, Sigma, St. Louis, MO).
RESULTS
Chromosomal mapping of mouse and human 
Prx-IV genes
Emerging evidence supports the importance
of peroxiredoxins in various aspects of redox
signaling (Jin and Jeang, 2000). Currently, six
subfamilies of mammalian peroxiredoxins have
been identified. To understand the human Prx-
IV gene better, we located it on the human
genome by sequence alignment. Using cDNA
information, we identified one genomic clone
that contained the complete coding and non-
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coding regions of human Prx-IV. This was a
BAC clone from the Genome Systems library I.
The clone identification number is GSHB-567I1
(GenBank AC005867). This clone maps to
Xp22.135–136. It is positive for DXS7178 and
SAT markers. The distance between Prx-IV and
SAT is within 100 kb. This map location was
confirmed by polymerase chain reaction (PCR)
analysis.
Approximately 46 kb of assembled sequence
from BAC clone GSHB-567I1 was obtained. The
human Prx-IV gene spans approximately 20 kb.
The sizes of all exons (Fig. 1A) and introns (Fig.
1B) were independently confirmed by PCR
analysis of human genomic DNA. The se-
quences of all splice junctions (Fig. 1B) and of
the 59 upstream region (Fig. 1C) were verified
by direct sequencing of PCR products. The hu-
man Prx-IV locus contains at least 7 exons. The
6 introns follow the usual GT/AG rule (Fig.
1B). The exons vary in size from 35 to 284 bp
(Fig. 1A). A putative TATA box (underlined)
was identified in the 59-flanking region. We
provided an accurate genomic definition of the
human Prx-IV locus. Our data are generally
consistent with the chromosomal map location
of human Prx-IV, which was reported to be
Xp21–22.1 (Haridas et al., 1998) or Xp21.3 (FISH
analysis; Matsumoto et al., 1999).
Molecular cloning of mouse Prx-IV
Previously, we defined the chromosomal
map location of Prx-IV gene in the mouse
genome (Lyu et al., 1999). A mouse Prx-IV
probe identified restriction site polymorphic
Pvu II fragments of 9.2 and 11.5 kb in NFS/N
and Mus spretus, respectively. These fragments
were mapped to mouse chromosome X with
the following gene order and distances: Htr1c-
2.3 6 1.6-Prdx4-1.66 1.6-Grpr. The murine re-
sults are generally consistent with the current
mapping data from human. The recent identi-
fication of human Prx-IV, provisionally called
AOE372 (Jin et al., 1997), provided us with the
information used to isolate a mouse ortholog.
Several ESTs cloned from the Soares mouse
(strain C57BL/6J) embryo (NbME13.5-14.5)
cDNA library (GenBank AA003828, W53950,
W98895) were identified in a BLAST homology
search against the full-length human Prx-IV se-
quence. One of these EST clones (GenBank
W53950; IMAGE Consortium clone 367356)
containing putative initiating ATG was ob-
tained, and its complete nucleotide sequence
was determined. Based on sequence data we
assembled an apparently complete cDNA ( , 1
kb) encoding mouse Prx-IV (Fig. 2). This se-
quence was deposited into GenBank under 
accession number U96746 (deposited, April,
1997). At time of deposition, there was no other
sequence available in the database for mouse
Prv-IV.
Mouse Prx-IV is predicted to be a 274-amino-
acid polypeptide. This size is comparable to the
human ortholog. A poly(A) tail is present at the
39 terminus of the cDNA. Mouse and human
Prx-IV share more than 89% identical amino
acids (Fig. 3A). Notably, about 75% of the nu-
cleotide changes between mouse and human
Prx-IV cDNAs are synonymous substitutions.
Thus, evolution of Prx-IV genes preserves pro-
tein-encoding functions. The primary amino
acid sequence (Figs. 2 and 3A) and the hydrop-
athy plot (data not shown) of mouse Prx-IV
confirmed the existence of an amino-terminal
signal peptide. Interestingly, this presequence
is the most diverged portion between mouse,
rat, and human Prx-IV (Fig. 3A). Excluding this
part of the protein, the mature Prx-IV polypep-
tides are extremely well conserved. Hence, ma-
ture mouse and human Prx-IV share 97.5%
amino acid identity.
We constructed a phylogenetic tree for rep-
resentative members of mammalian peroxire-
doxins (Fig. 3B). The tree clearly classifies the
currently known peroxiredoxins into six sub-
families. Prx-IV forms a separate grouping in
this tree, with strong bootstrap support (100%).
Notably, Prx-I, Prx-II, Prx-III, and Prx-IV are
closer to each other than to Prx-V or Prx-VI.
Thus, the former group of proteins may have
separated first from Prx-V and Prx-VI at an ear-
lier time and then subsequently diverged into
the four subfamilies (Prx-I, Prx-II, Prx-III, and
Prx-IV).
Expression of mouse Prx-IV mRNA
The availability of a novel mouse Prx-IV
cDNA prompted us to examine the expression
pattern of Prx-IV mRNA in mouse tissues by
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Northern blot analysis (Fig. 4). The Prx-IV
probe detected a single transcript of about 1.1
kb. Also shown in the lower panel are the sig-
nals for the 2.0-kb b-actin mRNA from the same
blot after reprobing with a b-actin cDNA. The
b-actin bands provide normalization for the
amount of mRNAs loaded into the different
lanes. Prx-IV was ubiquitously expressed in all
mouse tissues tested. These tissues included
heart, brain, spleen, lung, liver, (skeletal) mus-
cle, kidney, and testis. Prx-IV was most
strongly expressed in heart, (skeletal) muscle,
and testis mRNAs.
Expression and subcellular localization of 
mouse Prx-IV protein
Next, we raised specific antibody against a
synthetic Prx-IV peptide to examine the ex-
pression of Prx-IV protein in the two mouse cell
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FIG. 1. Characterization of human Prx-IV genomic sequences. (A) Sizes of exons. (B) Splice junctions and sizes of
introns. Exon sequences are in uppercase and introns are in lower case. Underlined are splice donor and acceptor
consensus dinucleotides. (C) Sequence of 59-flanking region in the human Prx-IV gene. Exons are in uppercase and
a TATA box was underlined.
lines NIH-3T3 (fibroblast) and F9 (embryonic
testicular teratoma). A band at about 25 kDa
was detected in the cell extracts of both lines
with the peptide-specific antiserum (Fig. 5A,
lanes 1 and 2), whereas the preimmune serum
failed to react with any protein in the same
range (data not shown). Previously, human
and rat Prx-IV proteins have been reported to
be secreted by Jurkat and COS-1 cells (Haridas
et al., 1998; Matsumoto et al., 1999). However,
although we could detect Prx-IV in the cell 
extracts of both untransfected (Fig. 5A) and
pSVP4-transfected (data not shown) NIH-3T3,
F9, and Jurkat (human T-lymphocyte) cells, we
failed to find any Prx-IV in 3 ml of conditioned
media from pSVP4-transfected NIH-3T3 or 
Jurkat cells (Fig. 5A, lanes 3 and 4).
We also determined the subcellular localiza-
tion of Prx-IV protein in NIH-3T3 cells by con-
focal immunofluorescence microscopy (Fig.
5B). Prx-IV was found in the nucleus-excluded
region (Fig. 5B, panel 1), consistent with a cy-
toplasmic and/or organellar localization. The
staining was specifically erased by preincuba-
tion of the anti-Prx-IV antiserum (372-1) with
the immunizing peptide (Fig. 5B, panel 2).
Thus, Prx-IV is primarily an intracellular cyto-
plasmic peroxiredoxin.
Prx-IV prevents intracellular ROS production
As a peroxidase, Prx-IV is thought to have a
function in intracellular redox. Presumably, it
impacts cell signaling and gene expression
through this mechanism. One redox-regulated
path involves growth factor-stimulated recep-
tor signaling (Sundaresan et al., 1995; Bae et al.,
1997). Here, a rapid increase in intracellular
ROS peaked within 5 min of stimulation of cells
with platelet-derived growth factor (PDGF) or
epidermal growth factor (EGF). This time
course of ROS production correlated with the
kinetics of the ligand-stimulated tyrosine phos-
phorylation. Another redox-mediated pathway
related to tumor suppression is p53-induced
apoptosis (Polyak et al., 1997). There is ample
evidence that p53-stimulated generation of in-
tracellular ROS is critically involved in mito-
chondrial permeability transition (Li et al.,
1999), which is one of the initial events in apop-
tosis. To shed additional light on the intracel-
lular antioxidant functions of mouse Prx-IV, we
asked whether it might modulate EGF- and
p53-induced ROS production.
EGF-stimulated generation of ROS was stud-
ied in A431 cells, which abundantly express
EGF receptors (Fig. 6A). Cells transfected with
pSVGal (control plasmid expressing b-galac-
tosidase) and pSVP4 (Prx-IV-expression vector)
were recognized by their reactivities with the
anti-b-galactosidase and anti-Prx-IV antibod-
ies, respectively. ROS level was measured by
the DCF fluorescence. In pSVGal-transfected
cells, the ROS concentration was found to in-
crease two-fold upon stimulation with EGF. In
contrast, this increase was not observed in stim-
ulated pSVP4-transfected cells (Fig. 6A). Thus,
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FIG. 2. Nucleotide and deduced amino acid sequence
of mouse Prx-IV. Sequence of the predicted signal pep-
tide is underlined. Sequence of the synthetic peptide used
to raise antibody in rabbit is double-underlined. This se-
quence has been deposited in GenBank under accession
number U96746.
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FIG. 3. Alignment and phylogenetic analysis of peroxiredoxin sequences. (A) Sequence alignment of mouse, rat,
and human Prx-IV proteins. Identical amino acids are shown as white against black. Conservative substitutions are
gray shaded. The GenBank accession numbers of human and rat Prx-IV sequences are U25182 and AF106945, re-
spectively. (B) Consensus distance-matrix tree of representative peroxiredoxins. Phylogenies were inferred from pro-
tein sequences using a distance-matrix. The tree was reconstructed using the neighbor-joining algorithm. Bootstrap
replication was performed and the majority rule consensus tree was generated from 100 replicates. Sequences were
extracted from the GenBank and SwissProt databases.
overexpression of mouse Prx-IV prevented
EGF-stimulated ROS production.
Next, we transfected a p53 expression plas-
mid (pp53) into NIH-3T3 cells and checked for
ROS level. The transient expression of p53 in-
duced a transient increase in intracellular ROS
as reflected by DCF fluorescence (Fig. 6B). In
p53-expressing cells, this increase was de-
tectable within 16 hr after transfection and
peaked at 24 hr. Cells were co-transfected with
pp53 and pSVP4 using calcium phosphate pre-
cipitation to ensure that both plasmids were
taken together into cells. DCF fluorescence at
both 16 and 24 hr was significantly weaker in
these co-transfected cells than that in cells
which were transfected with pp53 alone. In
control cells co-transfected with b-galactosi-
dase, the DCF fluorescence did not change.
These results suggest that the expression of
Prx-IV counteracted the generation of intracel-
lular ROS induced by p53.
DISCUSSION
In this study, we have identified the mouse
Prx-IV cDNA (Fig. 2) through homology
searching. Mouse Prx-IV is highly conserved
with its human and rat orthologs (Fig. 3A).
Evolutionarily Prx-IV is closer to Prx-I/-II/-III
than to Prx-V/-VI (Fig. 3B). Consistent with
previous mapping data in mouse and human,
human Prx-IV gene localized to chromosome
Xp22.135–136, is in close proximity to SAT. A
BAC clone containing the complete human Prx-
IV locus was also identified and characterized
(Fig. 1). Mouse Prx-IV is ubiquitously expressed
(Figs. 4 and 5A). However, in contrast with pre-
vious studies (Haridas et al., 1998; Matsumoto
et al., 1999), we failed to detect Prx-IV in the con-
ditioned media of NIH-3T3 and Jurkat cells (Fig.
5A). Mouse Prx-IV protein localized to the nu-
cleus-excluded region of cultured NIH-3T3 cells
(Fig. 5B). Inside cells, over-expression of mouse
Prx-IV can prevent ROS generation stimulated
by EGF and p53 (Fig. 6).
Examining the complete genomic clone of
Prx-IV revealed interestingly that the whole
signal peptide in human Prx-IV was encoded
within the first exon (Fig. 3A). Presumably, this
sorting signal may have evolved through a sin-
gle discrete gain-of-function event. Further in-
vestigations will elucidate the molecular mech-
anisms for the transcriptional regulation and
differential expression of Prx-IV gene.
Human and rat Prx-IV were previously
found in Jurkat- or COS-1-conditioned media
(Haridas et al., 1998; Matsumoto et al., 1999).
Surprisingly, while transfected rat Prx-IV was
previously detectable from only 10 ml of cul-
ture medium from COS-1 cells (Matsumoto et
al., 1999), we failed to detect Prx-IV from sam-
ples concentrated from 3 ml of either NIH-3T3-
or Jurkat-conditioned media (Fig. 5A). This
may suggest that extracellular secretion of pro-
tein is low. Because Prx-IV is expressed abun-
dantly inside cells, it is difficult to rule out the
possibility that the Prx-IV protein recovered
from culture supernatants originated from
lysed or apoptotic cells. Additionally, when we
incubated U937 (histiocytic lymphoma) cells
with purified recombinant Prx-IV, we failed to
observe any effects on NF-kB or c-Jun N-ter-
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FIG. 4. Expression of mouse Prx-IV mRNA. Northern
blot analysis was performed using multiple mouse tis-
sues. Positions of the molecular weight markers are
shown on the right.
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FIG. 5. Expression and subcellular localization of mouse Prx-IV protein. (A) Western blot analysis of Prx-IV pro-
tein in extracts of untransfected NIH-3T3 and F9 cells (lanes 1–2), and in conditioned media from pSVP4-transfected
NIH-3T3 and Jurkat cells (lanes 3–4). Positions of the molecular weight markers are shown on the right. Experiments
were repeated for four times with similar results. (B) Confocal immunofluorescence microscopy. NIH-3T3 cells were
washed, fixed, and stained individually with anti-Prx-IV antibody 372-1 (panel 1) or with 372-1 pre-incubated with
5 mg of immunizing peptide (panel 2).
FIG. 6. Mouse Prx-IV inhibits EGF- and p53-induced ROS production. (A) Influence on EGF-dependent ROS pro-
duction. A431 cells were transfected with control plasmid pSVGal or with pSVP4 expressing mouse Prx-IV. Trans-
fected cells were serum-deprived for 6 hr and treated with 0.5 mg of EGF for 5 min. Fluorescent dye was then added
and incubated with cells for 8 min. DCF fluorescence was measured and calculated as percentage of control (mocked-
treated pSVGal-transfected cells). Results represent the average of three independent experiments and error bars in-
dicate the standard error. DCF fluorescence data from EGF-stimulated pSVGal-transfected cells and EGF-stimulated
pSVP4-transfected cells were compared by Student’s t-test and the difference was found to be statistically significant
(p , 0.01). (B) Prx-IV counteracts p53-induced generation of ROS. NIH-3T3 cells were transfected individually with
the indicated plasmids (10 mg). DCF was added at the indicated time points after transfection, and the relative DCF
fluorescence was calculated as percentage of control (pSVGal-transfected cells at time zero). Results are representa-
tive of three independent experiments and the standard deviation of each point is less than 10%. Data collected at 24
hr after transfection were compared by Student’s t-test and the difference between pp53-transfected cells and cells
transfected with pp531 pSVP4 was statistically significant (p , 0.001). Consistent with results from A431 cells as
shown in A, transfection of NIH-3T3 cells with pSVP4 alone also led to a slight reduction in DCF fluorescence if com-
pared to pSVGal-transfected cells (data not shown).
minal kinase (JNK) (data not shown). Our re-
sults argue that the predominant Prx-IV activ-
ity is intracellular and that only a very small
amount could be secreted to function as an ex-
tracellular cytokine.
We note that DCFH2 can be oxidized by var-
ious ROS as well as reactive nitrogen species
(Crow, 1997). However, stimulation of ROS
production by EGF and p53 has already been
documented (Bae et al., 1997; Li et al., 1999;
Zhou et al., 2000), and we believed that this
stimulation could be sensitively and authenti-
cally reflected by DCF fluorescence. Here, we
have provided the first evidence that Prx-IV
functions as an antioxidant in mammalian cells
by preventing the production of intracellular
ROS (Fig. 6). Through this mechanism, Prx-IV
might regulate signal transduction as related to
EGF and p53, as well as other growth factors
and tumor suppressor proteins. Our data pro-
pose that Prx-IV is primarily a regulator of in-
tracellular redox.
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